financetom
Business
financetom
/
Business
/
US halt of wind project hurts New England grid reliability and jobs, officials say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US halt of wind project hurts New England grid reliability and jobs, officials say
Aug 25, 2025 11:47 AM

Aug 25 (Reuters) - The Trump administration's order to

halt work on a major wind farm under construction off the coast

of Rhode Island threatens grid reliability and jobs, energy and

labor officials said on Monday.

ISO New England, which operates the grid in six states, and

North America's Building Trades Unions made those criticisms in

statements after President Donald Trump's Interior Department on

Friday abruptly ordered work to stop on the Revolution Wind

project, which is 80% complete, citing unspecified national

security concerns.

Shares of project developer Orsted, which is based in

Denmark, sank to record lows on Monday.

"The ISO is expecting this project to come online and it is

included in our analyses of near-term and future grid

reliability," the grid operator for 15 million people said.

"Delaying the project will increase risks to reliability."

NABTU, an alliance of 14 building and construction unions,

said the order affected the jobs of 1,000 members.

"A 'stop-work order' is the fancy bureaucratic term, but it

means one thing: throwing skilled American workers off the job

after they've spent a decade training, building, and

delivering," NABTU President Sean McGarvey said in a statement.

Revolution Wind, which is off the coast of Rhode Island, was

scheduled to be completed next year and was expected to produce

enough electricity to power 350,000 homes in Rhode Island and

Connecticut.

The governors of those states, both Democrats, have also

criticized the Interior Department move, saying it jeopardized

jobs, energy affordability and electricity reliability.

An Interior Department spokesperson had no comment on the

stop-work order on Monday. The move was revealed in a letter to

Orsted late on Friday.

President Donald Trump, a Republican, has repeatedly

criticized wind energy as ugly, unreliable and expensive. His

administration has taken several steps to rein in wind

development.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Astria Therapeutics Says New Data Back Navenibart Dose Regimen for Hereditary Angioedema
Astria Therapeutics Says New Data Back Navenibart Dose Regimen for Hereditary Angioedema
Jun 13, 2025
08:00 AM EDT, 06/13/2025 (MT Newswires) -- Astria Therapeutics ( ATXS ) said Friday that initial results from its ongoing long-term open-label trial of navenibart in hereditary angioedema showed a significant reduction in monthly attack rates, supporting the potential for dosing schedules of every three or six months. The biopharmaceutical company said navenibart demonstrated an overall attack-freedom of 50% over...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Beam Therapeutics Reports Positive Update From Sickle Cell Disease Trial
Beam Therapeutics Reports Positive Update From Sickle Cell Disease Trial
Jun 13, 2025
07:45 AM EDT, 06/13/2025 (MT Newswires) -- Beam Therapeutics ( BEAM ) said updated results from 17 patients in its phase 1/2 BEACON trial evaluating BEAM-101, a base-editing therapy for severe sickle cell disease, showed robust and durable increases in fetal hemoglobin, reduced sickle hemoglobin, and normalized hemolysis markers. The company will present the new safety and efficacy data at...
J.C. Flowers-backed Jefferson Capital eyes $1.1 billion valuation in US IPO
J.C. Flowers-backed Jefferson Capital eyes $1.1 billion valuation in US IPO
Jun 13, 2025
(Reuters) -Private equity-backed Jefferson Capital said on Friday it was targeting a valuation of up to $1.1 billion in its U.S. initial public offering, as buyout firms look to take advantage of an improving new listings market. The company and some of its investors are seeking to raise up to $170 million by offering 10 million shares priced between $15...
Copyright 2023-2026 - www.financetom.com All Rights Reserved